Your browser doesn't support javascript.
loading
Antioxidant and hepatoprotective effects of Korean ginseng extract GS-KG9 in a D-galactosamine-induced liver damage animal model.
Jo, Yun Ho; Lee, Hwan; Oh, Myeong Hwan; Lee, Gyeong Hee; Lee, You Jin; Lee, Ji Sun; Kim, Min Jung; Kim, Won Yong; Kim, Jin Seong; Yoo, Dae Seok; Cho, Sang Won; Cha, Seon Woo; Pyo, Mi Kyung.
Afiliación
  • Jo YH; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Lee H; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Oh MH; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Lee GH; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Lee YJ; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Lee JS; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Kim MJ; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Kim WY; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Kim JS; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Yoo DS; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Cho SW; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Cha SW; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
  • Pyo MK; International Ginseng & Herb Research Institute, Geumsan 32724, Korea.
Nutr Res Pract ; 14(4): 334-351, 2020 Aug.
Article en En | MEDLINE | ID: mdl-32765814
BACKGROUND/OBJECTIVES: This study was designed to investigate the improvement effect of white ginseng extract (GS-KG9) on D-galactosamine (Ga1N)-induced oxidative stress and liver injury. SUBJECTS/METHODS: Sixty Sprague-Dawley rats were divided into 6 groups. Rats were orally administrated with GS-KG9 (300, 500, or 700 mg/kg) or silymarin (25 mg/kg) for 2 weeks. The rats of the GS-KG9- and silymarin-treated groups and a control group were then intraperitoneally injected Ga1N at a concentration of 650 mg/kg for 4 days. To investigate the protective effect of GS-KG9 against GalN-induced liver injury, blood liver function indicators, anti-oxidative stress indicators, and histopathological features were analyzed. RESULTS: Serum biochemical analysis indicated that GS-KG9 ameliorated the elevation of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) in GalN-treated rats. The hepatoprotective effects of GS-KG9 involved enhancing components of the hepatic antioxidant defense system, including glutathione, glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT). In addition, GS-KG9 treatment inhibited reactive oxygen species (ROS) production induced by GalN treatment in hepatocytes and significantly increased the expression levels of nuclear factor erythroid-2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) proteins, which are antioxidant proteins. In particular, by histological analyses bases on hematoxylin and eosin, Masson's trichrome, α-smooth muscle actin, and transforming growth factor-ß1 staining, we determined that the administration of 500 mg/kg GS-KG9 inhibited hepatic inflammation and fibrosis due to the excessive accumulation of collagen. CONCLUSIONS: These findings demonstrate that GS-KG9 improves GalN-induced liver inflammation, necrosis, and fibrosis by attenuating oxidative stress. Therefore, GS-KG9 may be considered a useful candidate in the development of a natural preventive agent against liver injury.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Nutr Res Pract Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Nutr Res Pract Año: 2020 Tipo del documento: Article